The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare, preventative treatments, early diagnosis, reducing patient recovery times and improving outcomes, and growing importance of technologies such as machine learning, augmented reality, 5G and digitalization. In the last three years alone, there have been over 230,000 patents filed and granted in the medical devices industry, according to GlobalData’s report on Innovation in medical: transdermal drug delivery. Buy the report here.
However, not all innovations are equal and nor do they follow a constant upward trend. Instead, their evolution takes the form of an S-shaped curve that reflects their typical lifecycle from early emergence to accelerating adoption, before finally stabilizing and reaching maturity.
Identifying where a particular innovation is on this journey, especially those that are in the emerging and accelerating stages, is essential for understanding their current level of adoption and the likely future trajectory and impact they will have.
35+ innovations will shape the medical devices industry
According to GlobalData’s Technology Foresights, which plots the S-curve for the medical devices industry using innovation intensity models built on over 165,000 patents, there are 35+ innovation areas that will shape the future of the industry.
Within the emerging innovation stage, ultrasonic nebulizers and intra-oral 3D imaging are disruptive technologies that are in the early stages of application and should be tracked closely. Automated diabetes management, cardiac stimulation implants, and transdermal drug delivery are some of the accelerating innovation areas, where adoption has been steadily increasing. Among maturing innovation areas is CPR assistance devices and fall detection monitoring, which is now well established in the industry.
Innovation S-curve for the medical devices industry
Transdermal drug delivery is a key innovation area in medical devices
Transdermal drug delivery is the process of administering drugs or active molecules by applying them to the skin, eliminating the requirement for oral intake or injections. This method allows drugs to be absorbed directly through the skin's barrier into the bloodstream.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. According to GlobalData, there are 200+ companies, spanning technology vendors, established medical devices companies, and up-and-coming start-ups engaged in the development and application of transdermal drug delivery.
Key players in transdermal drug delivery – a disruptive innovation in the medical devices industry
‘Application diversity’ measures the number of applications identified for each patent. It broadly splits companies into either ‘niche’ or ‘diversified’ innovators.
‘Geographic reach’ refers to the number of countries each patent is registered in. It reflects the breadth of geographic application intended, ranging from ‘global’ to ‘local’.
Patent volumes related to transdermal drug delivery
Source: GlobalData Patent Analytics
Inovio Pharmaceuticals is one of the leading patent filers in the field of transdermal drug delivery. Some other key patent filers in the field include L'Oreal, Groupe SEB, and NovoCure.
In terms of application diversity, Fe3 Medical leads the pack, while Vir Biotechnology and Boston Scientific stood in the second and third positions, respectively. By means of geographic reach, Valencell held the top position, followed by Broadcom and Sorrento Therapeutics.
The transdermal drug delivery method can potentially outperform traditional drug delivery routes due to its non-invasive nature, effectively addressing concerns such as needle phobia associated with parenteral routes. The demand for transdermal technologies will further increase by future advances in technology and approaches to improve targeted transdermal delivery.
To further understand the key themes and technologies disrupting the medical devices industry, access GlobalData’s latest thematic research report on Medical Devices.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.